Habitual intake of anthocyanins and flavanones and risk of cardiovascular disease in men

American Journal of Clinical Nutrition

Volumn 104, Issue 3, 2016, Pages 587-594

  Cassidy, Aedín ^a   Bertoia, Monica ^b   Chiuve, Stephanie ^b   Flint, Alan ^b   Forman, John ^c   Rimm, Eric B ^b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anthocyanins; Flavanones; Flavonoids; Heart disease; Men; Stroke

Indexed keywords

ANTHOCYANIN; FLAVANONE DERIVATIVE;

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; FRUIT; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; AGED; CHEMISTRY; FEEDING BEHAVIOR; HEALTH CARE PERSONNEL; HEALTHY DIET; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; RISK FACTOR; SELF REPORT; STROKE; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTHOCYANINS; BRAIN ISCHEMIA; COHORT STUDIES; FEEDING BEHAVIOR; FLAVANONES; FOLLOW-UP STUDIES; FRUIT; HEALTH PERSONNEL; HEALTHY DIET; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RISK FACTORS; SELF REPORT; STROKE; UNITED STATES;

EID: 84985987330     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.116.133132     Document Type: Article

References (60)

1. Ezzati M, Riboli E. Behavioral and dietary risk factors for noncommunicable diseases. N Engl J Med 2013;369:954-64.
2. Muraki I, Imamura F, Manson JE, Hu FB, Willett WC, van Dam RM, Sun Q. Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies. BMJ 2013;347:f5001.
3. Chanet A, Milenkovic D, Manach C, Mazur A, Morand C. Citrus flavanones: What is their role in cardiovascular protection? J Agric Food Chem 2012;60:8809-22.
4. Wedick NM, Pan A, Cassidy A, Rimm EB, Sampson L, Rosner B, Willett W, Hu FB, Sun Q, van Dam RM. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr 2012;95: 925-33.
5. Cassidy A, O'Reilly EJ, Kay C, Sampson L, Franz M, Forman JP, Curhan G, Rimm EB. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr 2011;93:338-47.
6. Cassidy A, Mukamal KJ, Liu L, Franz M, Eliassen AH, Rimm EB. High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle- Aged women. Circulation 2013; 127:188-96.
7. Cassidy A, Rogers G, Peterson JJ, Dwyer JT, Lin H, Jacques PF. Higher dietary anthocyanin and flavonol intakes are associated with anti-inflammatory effects in a population of US adults. Am J Clin Nutr 2015;102:172-81.
8. WHO. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva (Switzerland): WHO; 2009.
9. WHO. World health statistics 2009. Geneva (Switzerland): WHO; 2009.
10. Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, Kissela BM, Kittner SJ, Lichtman JH, Lisabeth LD, et al. Factors influencing the decline in stroke mortality: A statement from the American Heart Association/American Stroke Association. Stroke 2014;45:315-53.
11. Lamy S, Beaulieu E, Labbe D, Bedard V, Moghrabi A, Barrette S, Kissela BM, Kittner SJ, Lichtman JH, Lisabeth LD, et al. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling. Carcinogenesis 2008;29:1033-41.
12. Toufektsian MC, de Lorgeril M, Nagy N, Salen P, Donati MB, Giordano L, Mock HP, Peterek S, Matros A, Petroni K, et al. Chronic dietary intake of plant-derived anthocyanins protects the rat heart against ischemiareperfusion injury. J Nutr 2008;138:747-52.
13. Rizza S, Muniyappa R, Iantorno M, Kim JA, Chen H, Pullikotil P, Senese N, Tesauro M, Lauro D, Cardillo C, et al. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab 2011;96:E782-92.
14. Jin YR, Han XH, Zhang YH, Lee JJ, Lim Y, Chung JH, Yun YP. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity. Atherosclerosis 2007;194:144-52.
15. Erlund I, Koli R, Alfthan G, Marniemi J, Puukka P, Mustonen P, Mattila P, Jula A. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr 2008;87:323-31.
16. Basu A, Du M, Leyva MJ, Sanchez K, Betts NM, Wu M, Aston CE, Lyons TJ. Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J Nutr 2010;140:1582-7.
17. Johnson SA, Figueroa A, Navaei N, Wong A, Kalfon R, Ormsbee LT, Feresin RG, Elam ML, Hooshmand S, Payton ME, et al. Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- And stage 1-hypertension: A randomized, double-blind, placebo-controlled clinical trial. J Acad Nutr Diet 2015;115:369-77.
18. Dohadwala MM, Holbrook M, Hamburg NM, Shenouda SM, Chung WB, Titas M, Kluge MA, Wang N, Palmisano J, Milbury PE, et al. Effects of cranberry juice consumption on vascular function in patients with coronary artery disease. Am J Clin Nutr 2011;93:934-40.
19. Habauzit V, Verny MA, Milenkovic D, Barber-Chamoux N, Mazur A, Dubray C, Morand C. Flavanones protect from arterial stiffness in postmenopausal women consuming grapefruit juice for 6 mo: A randomized, controlled, crossover trial. Am J Clin Nutr 2015;102:66-74.
20. Morand C, Dubray C, Milenkovic D, Lioger D, Martin JF, Scalbert A, Mazur A. Hesperidin contributes to the vascular protective effects of orange juice: A randomized crossover study in healthy volunteers. Am J Clin Nutr 2011;93:73-80.
21. Basu A, Betts NM, Nguyen A, Newman ED, Fu D, Lyons TJ. Freeze-dried strawberries lower serum cholesterol and lipid peroxidation in adults with abdominal adiposity and elevated serum lipids. J Nutr 2014;144:830-7.
22. Zhu Y, Huang X, Zhang Y, Wang Y, Liu Y, Sun R, Xia M. Anthocyanin supplementation improves HDL- Associated paraoxonase 1 activity and enhances cholesterol efflux capacity in subjects with hypercholesterolemia. J Clin Endocrinol Metab 2014;99:561-9.
23. Zhu Y, Ling W, Guo H, Song F, Ye Q, Zou T, Li D, Zhang Y, Li G, Xiao Y, et al. Anti-inflammatory effect of purified dietary anthocyanin in adults with hypercholesterolemia: A randomized controlled trial. Nutr Metab Cardiovasc Dis 2013;23:843-9.
24. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong CP, Nettleton JA, Jacobs DR Jr. Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am J Clin Nutr 2007; 85:895-909.
25. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 2012;95:454-64.
26. Cassidy A, Rimm EB, O'Reilly EJ, Logroscino G, Kay C, Chiuve SE, Rexrode KM. Dietary flavonoids and risk of stroke in women. Stroke 2012;43:946-51.
27. Jacques PF, Cassidy A, Rogers G, Peterson JJ, Dwyer JT. Dietary flavonoid intakes and CVD incidence in the Framingham Offspring Cohort. Br J Nutr 2015;114:1496-503.
28. Peterson JJ, Dwyer JT, Jacques PF, McCullough ML. Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr Rev 2012;70:491-508.
29. Wang X, Ouyang YY, Liu J, Zhao G. Flavonoid intake and risk of CVD: A systematic review and meta- Analysis of prospective cohort studies. Br J Nutr 2014;111:1-11.
30. Mursu J, Voutilainen S, Nurmi T, Tuomainen TP, Kurl S, Salonen JT. Flavonoid intake and the risk of ischaemic stroke and CVD mortality in middle- Aged Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr 2008;100:890-5.
31. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliovaara M, Reunanen A, Hakulinen T, Aromaa A. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 2002;76:560-8.
32. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self- Administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-26.
33. Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M, Willett W. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med 1990;323:1026-32.
34. WHO. Cardiovascular survey methods. Geneva (Switzerland): WHO; 1982.
35. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke. Clinical findings. Stroke 1981;12(Suppl 1):I13-I44.
36. Salvini S, Hunter DJ, Sampson L, Stampfer MJ, Colditz GA, Rosner B, Willett WC. Food-based validation of a dietary questionnaire: The effects of week- To-week variation in food consumption. Int J Epidemiol 1989;18:858-67.
37. Feskanich D, Rimm EB, Giovannucci EL, Colditz GA, Stampfer MJ, Litin LB, Willett WC. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790-6.
38. Krogholm KS, Bysted A, Brantsaeter AL, Jakobsen J, Rasmussen SE, Kristoffersen L, Toft U. Evaluation of flavonoids and enterolactone in overnight urine as intake biomarkers of fruits, vegetables and beverages in the Inter99 cohort study using the method of triads. Br J Nutr 2012; 108:1904-12.
39. Therneau TM, Grambsch PM, editors. Modeling survival data: extending the Cox Model. New York: Springer; 2000.
40. Bhagwat S, Haytowitz DB, Holden JM, editors. USDA database for the flavonoid content of selected foods: release 3.1. Washington (DC): USDA; 2014.
41. USDA. National nutrient database for standard reference: release 28. Washington (DC): USDA; 2015.
42. Rendeiro C, Rhodes JS, Spencer JP. The mechanisms of action of flavonoids in the brain: direct versus indirect effects. Neurochem Int 2015;89:126-39.
43. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005;81(1 Suppl):243S-255S.
44. Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice- Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 2003;85:180-92.
45. Bhupathiraju SN, Wedick NM, Pan A, Manson JE, Rexrode KM, Willett WC, Rimm EB, Hu FB. Quantity and variety in fruit and vegetable intake and risk of coronary heart disease. Am J Clin Nutr 2013;98:1514-23.
46. Liu XX, Li SH, Chen JZ, Sun K, Wang XJ, Wang XG, Hui RT. Effect of soy isoflavones on blood pressure: A meta- Analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2012;22:463-70.
47. Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, Cassidy A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: A systematic review and meta- Analysis of randomized trials. Am J Clin Nutr 2012;95:740-51.
48. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, Ryder JJ, Hall WL, Cassidy A. Flavonoids, flavonoid-rich foods, and cardiovascular risk: A meta- Analysis of randomized controlled trials. Am J Clin Nutr 2008;88:38-50.
49. Edirisinghe I, Banaszewski K, Cappozzo J, Sandhya K, Ellis CL, Tadapaneni R, Kappagoda CT, Burton-Freeman BM. Strawberry anthocyanin and its association with postprandial inflammation and insulin. Br J Nutr 2011;106:913-22.
50. Milbury PE, Kalt W. Xenobiotic metabolism and berry flavonoid transport across the blood-brain barrier. J Agric Food Chem 2010;58: 3950-6.
51. Liu Y, Tan D, Shi L, Liu X, Zhang Y, Tong C, Song D, Hou M. Blueberry anthocyanins-enriched extracts attenuate cyclophosphamide- induced cardiac injury. PLoS One 2015;10:e0127813.
52. Vafeiadou K, Vauzour D, Lee HY, Rodriguez-Mateos A, Williams RJ, Spencer JP. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch Biochem Biophys 2009;484:100-9.
53. Menze ET, Tadros MG, Abdel-Tawab AM, Khalifa AE. Potential neuroprotective effects of hesperidin on 3-nitropropionic acid-induced neurotoxicity in rats. Neurotoxicology 2012;33:1265-75.
54. Choi EJ, Ahn WS. Neuroprotective effects of chronic hesperetin administration in mice. Arch Pharm Res 2008;31:1457-62.
55. Kean RJ, Lamport DJ, Dodd GF, Freeman JE, Williams CM, Ellis JA, Butler LT, Spencer JP. Chronic consumption of flavanone-rich orange juice is associated with cognitive benefits: An 8-wk, randomized, double-blind, placebo-controlled trial in healthy older adults. Am J Clin Nutr 2015;101:506-14.
56. Thomas-Barberan FA, Clifford MN. Flavanones, chalcones and dihydrochalcones-nature, occurrence and dietary burden. J Sci Food Agric 2000;80:1073-80.
57. Czank C, Cassidy A, Zhang Q, Morrison DJ, Preston T, Kroon PA, Botting NP, Kay CD. Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: A (13)C- Tracer study. Am J Clin Nutr 2013;97:995-1003.
58. de Ferrars RM, Czank C, Zhang Q, Botting NP, Kroon PA, Cassidy A, Kay CD. The pharmacokinetics of anthocyanins and their metabolites in humans. Br J Pharmacol 2014;171:3268-82.
59. Schär MY, Curtis PJ, Hazim S, Ostertag LM, Kay CD, Potter JF, Cassidy A. Orange juice-derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: A randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease. Am J Clin Nutr 2015;101:931-8.
60. Achaintre D, Bulete A, Cren-Olive C, Li L, Rinaldi S, Scalbert A. Differential isotope labeling of 38 dietary polyphenols and their quantification in urine by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Chem 2016;88:2637-44.